Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 1 — POCT-DOAC 1

Anticoagulation With Direct Oral Anticoagulants Clinical Trial

Official title:
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 1

Status Completed

Clinical Trial Summary

The investigators study aims to test the correlation between the CoaguChek point-of-care testing (POCT) device (Roche, Switzerland) and low plasma levels of all three currently approved direct oral anticoagulants (DOAC; rivaroxaban, apixaban and dabigatran) and to determine the diagnostic accuracy of POCT to rule out or detect relevant levels of DOAC in real-life stroke patients.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Anticoagulation With Direct Oral Anticoagulants

Clinical Trial Details

NCT number	NCT02371044
Study type	Observational
Source	University Hospital Tuebingen
Contact
Status	Completed
Phase	N/A
Start date	May 2013
Completion date	September 2014

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT04679298` - Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants Extended
	Completed	`NCT02371070` - Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2	N/A